SSB1/SSB2 proteins safeguard B-cell development by protecting the genomes of B-cell precursors
File(s)3423.full.pdf (2.33 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Induction of programmed DNA damage and its recognition and repair are fundamental for B cell development. The ssDNA-binding protein SSB1 has been described in human cells as essential for the recognition and repair of DNA damage. To study its relevance for B cells, we recently developed Ssb1−/− and conditional Ssb1−/− mice. Although SSB1 loss did not affect B cell development, Ssb1−/− cells exhibited compensatory expression of its homolog SSB2. We have now generated Ssb2−/− mice and show in this study that SSB2 is also dispensable for B cell development and DNA damage response activation. In contrast to the single loss of Ssb1 or Ssb2, however, combined SSB1/2 deficiency caused a defect in early B cell development. We relate this to the sensitivity of B cell precursors as mature B cells largely tolerated their loss. Toxicity of combined genetic SSB1/2 loss can be rescued by ectopic expression of either SSB1 or SSB2, mimicked by expression of SSB1 ssDNA-binding mutants, and attenuated by BCL2-mediated suppression of apoptosis. SSB1/2 loss in B cell precursors further caused increased exposure of ssDNA associated with disruption of genome fragile sites, inefficient cell cycle progression, and increased DNA damage if apoptosis is suppressed. As such, our results establish SSB1/2 as safeguards of B cell development and unveil their differential requirement in immature and mature B lymphocytes.
Date Issued
2019-06-15
Date Acceptance
2019-04-16
Citation
Journal of Immunology, 2019, 202 (12), pp.3423-3433
ISSN
1550-6606
Publisher
American Association of Immunologists
Start Page
3423
End Page
3433
Journal / Book Title
Journal of Immunology
Volume
202
Issue
12
Copyright Statement
© 2019 The Authors This article is distributed under the terms of the CC BY 4.0 Unported license (https://creativecommons.org/licenses/by/4.0/)
Sponsor
Action Against Cancer
Bloodwise
Bloodwise
Leuka
Commission of the European Communities
Grant Number
N/A
13016
13016
P47415
630911
Subjects
Immunology
1107 Immunology
Publication Status
Published
Date Publish Online
2019-06-03